학술논문

Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
Document Type
Article
Source
In: Journal for ImmunoTherapy of Cancer. (Journal for ImmunoTherapy of Cancer, 2 February 2024, 12(2))
Subject
Language
English
ISSN
20511426